Last updated on May 2017

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention


Brief description of study

This study will test PANO in combination with tacrolimus/sirolimus (TAC/SIR) for acute GVHD prevention. The purpose of this study is to determine if Panobinostat (PANO) when used in combination with sirolimus and tacrolimus will help reduce the incidence of Graft-vs-host disease (GVHD).

Clinical Study Identifier: NCT02588339

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Lia Perez, M.D.

H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL United States
  Connect »